Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis

John J. Kelly, Edward H. Lambert, Vanda A. Lennon

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Recent evidence indicates that in chronic experimental autoimmune myasthenia gravis (EAMG) and in human myasthenia gravis, the defect of neuromuscular transmission results from immune‐mediated destruction of postsynaptic membrane at the neuromuscular junction, with a reduction in the density of acetylcholine (ACh) receptors and decreased sensitivity to ACh released by nerve impulses. In the present study, the amount of ACh released by nerve impulse in rats with chronic EAMG and control rats of the same age, weight, and sex was compared. Phrenic nerve–hemidiaphragm preparations were stimulated in vitro, and the amount of ACh released was meansured by bioassay. Despite a marked reduction in the amplitude of miniature end‐plate potentials in chronic EAMG, ACh output at rest and during stimulation was not different from that of control rats. These data support the concept that the defect of neuromuscular transmission is due to a reduction of postsynaptic sensitivity to ACh.

Original languageEnglish (US)
Pages (from-to)67-72
Number of pages6
JournalAnnals of neurology
Volume4
Issue number1
DOIs
StatePublished - Jul 1978

    Fingerprint

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this